ImmunoAnalysis and Research Specimen Management
ImmunoAnalysis and Research Specimen Management
批准号:
7963221
负责人:
JAMES L MOHLER
金额:
$17.39万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2015-03-31
关键词:
Acinus organ componentAndrogen MetabolismAndrogen ReceptorAndrogensAntibodiesApoptosisArchivesBiochemicalBiological MarkersBromodeoxyuridineClinicalData AnalysesElongation FactorEnzymesEvaluationFreezingGenitourinary systemGrowth FactorHistologyHumanHuman Glandular Kallikrein 2Human ResourcesImageImage AnalysisImmunohistochemistryIn SituIndividualKi-67 AntigenLasersLeadMalignant neoplasm of prostateManuscriptsMeasurementMethodsMonoclonal AntibodiesNeuronsPaperParaffin EmbeddingPathologyProcessProteinsPublicationsPublishingRecurrenceResearchResearch PersonnelServicesSpecimenStaining methodStainsStem cellsSteroid ReceptorsThioredoxinTissue MicroarrayTissuesTranslationsTubulinUrinary RetentionVisualXenograft procedureangiogenesisenolaseinterestmenprogramsprotein expressionreceptortumor
中文摘要
核心B将为计划项目提供3个主要功能。首先,核心B将向研究者提供研究标本,并协助进行鉴定、免疫染色和图像分析。将从原始肿瘤或组织微阵列提供石蜡包埋切片,并用于1)使用Roufine H&E确认组织组织学; 2)使用ACINUS分析细胞凋亡,使用MIB-1分析增殖,使用单克隆抗体通过标准、描述性免疫组织化学和使用视觉评分和/或自动图像分析的定量分析检测Ki-67或BrdU掺入和雄激素受体;和3)鉴定和定量类固醇受体辅助调节剂、雄激素代谢酶、雄激素调节的基因产物1、α-微管蛋白、翻译延伸因子la、非神经元烯醇化酶、tomoregulin、硫氧还蛋白还原酶1、Mxi-1和人激肽释放酶2),一般转录因子,生长因子及其受体和干细胞和血管生成生物标志物。
其次,核心B将负责临床(冷冻、存档和TMA)和前列腺癌异种移植(CWR 22)研究标本的储存、处理和切片。核心人员将从因局部复发而出现尿潴留的晚期前列腺癌男性患者中采集、处理和储存去势复发性前列腺癌的临床标本。研究样本将用于构建组织微阵列或激光捕获显微切割用于裂隙雄激素的生化测量。最后,核心B将为项目提供专家生物统计学(Wilding博士)和泌尿生殖病理学服务(Alexiev博士)。
Drs.莫勒和史密斯将共同指导该设施,并监督已经完成的个人的活动。
拥有高水平的专业知识,目前正在为计划项目履行这些职能。Wilding和Alexiev博士将领导将生物统计学和病理学专业知识整合到核心B和3个项目中的工作。Core B发表的8篇方法论文最好地证明了Core B的高水平功能。核心B继续开发新的方法,以更准确地测量蛋白质表达(4出版物),并仍然是一个领导者,在使用TMA的CaP研究(2出版物)。核心B所提供的服务已导致项目1(20)、项目2(8)和项目3(8)的手稿出版、付印和提交。核心项目B还促进了项目之间的互动; 23份出版物中有12份涉及一个以上的项目。
英文摘要
Core B wiil provide 3 primary funcfions to the Program Project. First, Core B will provide research specimens to the investigators and assist with identificafion, immunostaining and image analysis. Paraffin-embedded sections will be provided from original tumors or tissue microarrays and used to 1) confirm tissue histology using roufine H&E; 2) analyze apoptosis using ACINUS, proliferation using MIB-1 detecfion of Ki-67 or BrdU incorporation and androgen receptor using monoclonal antibodies by standard, descriptive immunohistochemistry and quanfitative analysis using visual scoring and/or automated image analysis; and 3) idenfify and quanfify steroid receptor co-regulators, androgen metabolism enzymes, androgen-regulated gene products (PSA, Nkx3.1, a-tubulin, translation elongation factor la, non-neuronal enolase, tomoregulin, thioredoxin reducatase 1, Mxi-1 and human kallikrein 2), general transcripfion factors, growth factors and their receptors and stem cell and angiogenesis biomarkers using immunohistochemistry and image analysis.
Second, Core B will be responsible for storage, processing and sectioning of clinical (frozen, archival and TMAs) and prostate cancer xenograft (CWR22) research specimens. Core personnel will procure, process and store clinical specimens of castrafion-recurrent prostate cancer obtained from men with advanced prostate cancer who present with urinary retention due to local recurrence. Research specimens will be used to construct tissue microarrays or laser capture microdissected for biochemical measurements of fissue androgens. Lastly, Core B will provide expert biostatistical (Dr. Wilding) and genitourinary pathological service (Dr. Alexiev) to the Program Project.
Drs. Mohler and Smith will co-direct the facility and supervise the acfivifies of individuals who already
possess high levels of expertise and currently perform these funcfions for the Program Project. Drs. Wilding and Alexiev will lead the efforts to integrate biostatistical and pathological expertise into Core B and the 3 projects. The high level of funcfion of Core B is demonstrated best by Core B's publicafion of 8 methods papers. Core B continues to develop new methods for more accurate measurement of protein expression (4 publicafions) and remains a leader in the use of TMAs for CaP research (2 publications). Core B has performed services that have resulted in manuscripts published, in press and submitted for Project 1 (20), Project 2 (8) and Project 3 (8). Core B also facilitates interaction among the Projects; 12 of 23 publications involved more than 1 Project.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interference with Androgen Receptor and Its Ligands
-
批准号:8243673
-
项目类别:
-
资助金额:$34.77万
-
财政年份:2011
-
负责人:JAMES L MOHLER
-
依托单位:
ImmunoAnalysis and Research Specimen Management
-
批准号:8243677
-
项目类别:
-
资助金额:$22.98万
-
财政年份:2011
-
负责人:JAMES L MOHLER
-
依托单位:
Interference with Androgen Receptor and Its Ligands
-
批准号:7963169
-
项目类别:
-
资助金额:$63.3万
-
财政年份:2010
-
负责人:JAMES L MOHLER
-
依托单位:
CORE B
-
批准号:7141857
-
项目类别:
-
资助金额:$9.75万
-
财政年份:2005
-
负责人:JAMES L MOHLER
-
依托单位:
Project 1
-
批准号:7141833
-
项目类别:
-
资助金额:$34.61万
-
财政年份:2005
-
负责人:JAMES L MOHLER
-
依托单位:
CORE--IMMUNOANALYSIS
-
批准号:6652761
-
项目类别:
-
资助金额:$20.83万
-
财政年份:2002
-
负责人:JAMES L MOHLER
-
依托单位:
ANDROGEN RECEPTOR EXPRESSION AND FUNCTION IN PROSTATE CANCER
-
批准号:6652759
-
项目类别:
-
资助金额:$20.83万
-
财政年份:2002
-
负责人:JAMES L MOHLER
-
依托单位:
CORE--IMMUNOANALYSIS
-
批准号:6484139
-
项目类别:
-
资助金额:$20.83万
-
财政年份:2001
-
负责人:JAMES L MOHLER
-
依托单位:
ANDROGEN RECEPTOR EXPRESSION AND FUNCTION IN PROSTATE CANCER
-
批准号:6484137
-
项目类别:
-
资助金额:$20.83万
-
财政年份:2001
-
负责人:JAMES L MOHLER
-
依托单位:
BISPECIFIC ANTIBODY MDX H210 COMBINED W/ GM CSF IN PROSTATE CANCER
-
批准号:6566074
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2001
-
负责人:JAMES L MOHLER
-
依托单位:
CORE--IMMUNOANALYSIS
-
批准号:6344767
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2000
-
负责人:JAMES L MOHLER
-
依托单位:
BISPECIFIC ANTIBODY MDX H210 COMBINED W/ GM CSF IN PROSTATE CANCER
-
批准号:6423245
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2000
-
负责人:JAMES L MOHLER
-
依托单位:
ANDROGEN RECEPTOR EXPRESSION AND FUNCTION IN PROSTATE CANCER
-
批准号:6344765
-
项目类别:
-
资助金额:$27.96万
-
财政年份:2000
-
负责人:JAMES L MOHLER
-
依托单位:
BISPECIFIC ANTIBODY MDX H210 COMBINED W/ GM CSF IN PROSTATE CANCER
-
批准号:6504222
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2000
-
负责人:JAMES L MOHLER
-
依托单位:
CORE--IMMUNOANALYSIS
-
批准号:6203461
-
项目类别:
-
资助金额:$27.96万
-
财政年份:1999
-
负责人:JAMES L MOHLER
-
依托单位:
ANDROGEN RECEPTOR EXPRESSION AND FUNCTION IN PROSTATE CANCER
-
批准号:6203457
-
项目类别:
-
资助金额:$27.96万
-
财政年份:1999
-
负责人:JAMES L MOHLER
-
依托单位:
BISPECIFIC ANTIBODY MDX H210 COMBINED W/ GM CSF IN PROSTATE CANCER
-
批准号:6297233
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:JAMES L MOHLER
-
依托单位:
PROSTATE CANCER: TRANSITION TO ANDROGEN-INDEPENDENCE
-
批准号:6173639
-
项目类别:
-
资助金额:$112.65万
-
财政年份:1998
-
负责人:JAMES L MOHLER
-
依托单位:
PROSTATE CANCER: TRANSITION TO ANDROGEN-INDEPENDENCE
-
批准号:2893735
-
项目类别:
-
资助金额:$111.86万
-
财政年份:1998
-
负责人:JAMES L MOHLER
-
依托单位:
ANDROGEN RECEPTOR FUNCTION IN PROSTATE CANCER
-
批准号:6103477
-
项目类别:
-
资助金额:$8.5万
-
财政年份:1998
-
负责人:JAMES L MOHLER
-
依托单位:
海外基金